Microglia-astrocyte interplay mitigates Aβ toxicity in a novel human 3D neurosphere model of Alzheimer's Disease
BackgroundAlzheimers Disease (AD) is characterized by progressive amyloid beta (A{beta}) deposition in the brain, with eventual widespread neurodegeneration. While the cell-specific molecular signature of end-stage AD is reasonably well characterized through autopsy material, less is known about the molecular pathways in the human brain involved in the earliest exposure to A{beta}. Human model systems that not only replicate the pathological features of AD but also the transcriptional landscape in neurons, astrocytes and microglia are crucial for understanding disease mechanisms and for identifying novel therapeutic targets. MethodsIn this study, we used a human 3D iPSC-derived neurosphere model to explore how resident neurons, microglia and astrocytes and their interplay are modified by chronic amyloidosis induced over 3 to 5 weeks by supplementing media with synthetic A{beta}1-42 oligomers. Neurospheres under chronic A{beta} exposure were grown with or without microglia to investigate the functional roles of microglia. Neuronal activity and oxidative stress were monitored using genetically encoded indicators, including GCaMP6f and roGFP1, respectively. Single nuclei RNA sequencing (snRNA-seq) was performed to profile A{beta} and microglia driven transcriptional changes in neurons and astrocytes, providing a comprehensive analysis of cellular responses. ResultsMicroglia efficiently phagocytosed A{beta} inside neurospheres and significantly reduced neurotoxicity, mitigating amyloidosis-induced oxidative stress and neurodegeneration following different exposure times to A{beta}. The neuroprotective effects conferred by the presence of microglia was associated with unique gene expression profiles in astrocytes and neurons, including several known AD-associated genes such as APOE. These findings reveal how microglia can directly alter the molecular landscape of AD. ConclusionsOur human 3D neurosphere culture system with chronic A{beta} exposure reveals how microglia may be essential for the cellular and transcriptional responses in AD pathogenesis. Microglia are not only neuroprotective in neurospheres but also act as key drivers of A{beta}-dependent APOE expression suggesting critical roles for microglia in regulating APOE in the AD brain. This novel, well characterized, functional in vitro platform offers unique opportunities to study the roles and responses of microglia to A{beta} modelling key aspects of human AD. This tool will help identify new therapeutic targets, accelerating the transition from discovery to clinical applications. HighlightsO_LIWell-characterized functional human iPSC-derived 3D neurospheres (hiNS) consisting of neurons and astrocytes can be supplemented with microglia/macrophages (hiMG) C_LIO_LIChronic amyloidosis in the presence of hiMG recapitulate key features and gene expression profiles of AD C_LIO_LIhiMG within the model phagocytose A{beta} and mitigate A{beta}-induced neurotoxicity, reducing oxidative stress and neuronal damage C_LIO_LIhiMG are essential for A{beta} to upregulate AD-like gene expression signatures in astrocytes C_LIO_LIImmunohistochemical analysis reveals hiMG-dependent colocalization of A{beta} and APOE C_LI